Specifically, our findings revealed that NCAPD3 functions as an oncogene, promoting the proliferation of NSCLC cells while inhibiting apoptosis via the PI3K/AKT/FOXO4 signaling pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.